PCT (PCTL) Change In Receivables : $0.27 Mil (TTM As of Sep. 2022)

View and export this data going back to . Start your Free Trial

What is PCT Change In Receivables?

PCT's change in receivables for the quarter that ended in Sep. 2022 was $0.07 Mil. It means PCT's Accounts Receivable declined by $0.07 Mil from Jun. 2022 to Sep. 2022 .

PCT's change in receivables for the fiscal year that ended in Dec. 2021 was $0.21 Mil. It means PCT's Accounts Receivable declined by $0.21 Mil from Dec. 2020 to Dec. 2021 .

PCT's Accounts Receivable for the quarter that ended in Sep. 2022 was $0.03 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PCT's Days Sales Outstanding for the three months ended in Sep. 2022 was 7.89.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PCT's liquidation value for the three months ended in Sep. 2022 was $-5.63 Mil.

PCT Change In Receivables Historical Data

The historical data trend for PCT's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCT Change In Receivables Chart

PCT Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

-0.01

-0.04

-0.16

-0.28

0.21

PCT Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Change In Receivables	Get a 7-Day Free Trial															-0.07	0.21	-	-0.01	0.07

PCT Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.27 Mil.

PCT (OTCPK:PCTL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PCT's Days Sales Outstanding for the quarter that ended in Sep. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.025	/	0.289	*	91
=	7.89

2. In Ben Graham's calculation of liquidation value, PCT's accounts receivable are only considered to be worth 75% of book value:

PCT's liquidation value for the quarter that ended in Sep. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.031	-	5.695	+	0.75 * 0.025	+	0.5 * 0.039
=	-5.63

PCT Change In Receivables Related Terms

Thank you for viewing the detailed overview of PCT's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

PCT (PCTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » PCT Ltd (OTCPK:PCTL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

4235 Commerce Street, Little River, SC, USA, 29566

Website

https://www.pctl.com

PCT Ltd is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company provides innovative products and technologies for eliminating contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. The company markets new products and technologies for the Healthcare, Agriculture, and Oil & Gas industries. It designs, develops, integrates, assembles and commercializes technologies, products and systems targeted at the prevention and treatment of infectious disease and crop infestation. Its products include The Annihilyzer System, Large Volume Systems, Small Volume Systems, The Survivalyte System, and others.

Executives

Jody Read Francis	director, officer: Chief Operating Officer	9600 SW 67TH PATH, LAKE BUTLER FL 32054
Paul Branagan	director
William E Prince	director
Gary Grieco	director, 10 percent owner, officer: President	10457 W. 84TH TERRACE, LENEXA KS 66214
Gregory W Albers	director, officer: Secretary/Treasurer	10457 W. 84TH TERRACE, LENEXA KS 66214
John W Peters	director, officer: Secretary/Treasurer	2157 S LINCOLN STREET, SALT LAKE CITY UT 84106